THE AMERICA ONE NEWS
Sep 30, 2025  |  
0
 | Remer,MN
Sponsor:  QWIKET 
Sponsor:  QWIKET 
Sponsor:  QWIKET: Elevate your fantasy game! Interactive Sports Knowledge.
Sponsor:  QWIKET: Elevate your fantasy game! Interactive Sports Knowledge and Reasoning Support for Fantasy Sports and Betting Enthusiasts.
back  
topic
Virginia Kruta


NextImg:Trump Has Oval Office Crowd Rolling After Off-The-Cuff COVID Crack

President Donald Trump got a laugh from the crowd gathered in the Oval Office on Tuesday when he cracked a COVID-related joke at the expense of Health & Human Services Secretary Robert F. Kennedy Jr.

Trump and the others were in the middle of his press conference — announcing a massive reduction in many popular drugs thanks to a commitment from pharmaceutical giant Pfizer to invest $70 billion in domestic drug manufacturing — when Kennedy was unfortunate enough to sneeze.

WATCH:

Trump was in the middle of a thought about his plans to make additional efforts down the road to reduce prices even more for American families — but when Kennedy shielded his face with his elbow and sneezed, he responded immediately. Turning toward Kennedy, he said without missing a beat, “God bless you, Bobby.”

”I hope I didn’t just catch COVID just there,” he added after a brief pause as laughter began to erupt around the room. “Do you have a Paxlovid? Paxlovid? GIVE ME A PAXLOVID, IMMEDIATELY!”

As The Daily Wire reported previously, the new TrumpRX website will allow Americans to purchase drugs directly from the government rather than going through insurance. Virtually all drugs will be discounted on TrumpRX, the White House said.

Get 40% off new DailyWire+ annual memberships with code FALL40 at checkout

Pfizer stepped up with a $70 billion investment, signaling a shift toward making more drugs in the United States instead of continuing to rely on imports from other nations — some of which are considered adversaries. The Trump administration has identified that reliance as a national security issue.

Trump also suggested that his administration would be working with other drug companies in addition to Pfizer in an effort to increase the number of drugs that would be made available at discounted rates.